Skip to main content

Mammalian Biosynthesis of Potential Psychotogens Derived from Dopamine

  • Chapter
Catecholamines and Behavior · 1

Abstract

Normal mental functions can be disrupted by many kinds of drugs. Hallucinogens are of special interest because of their ability to impair higher centers without producing substantial effect on other functions of the central nervous system. While the mechanism of action of hallucinogens has not been clarified, the striking structural resemblance between certain of these agents and several central nervous system transmitters has not gone unnoticed (Osmond and Smythies, 1952; Snyder and Merril, 1965). Mescaline, for example, bears a strong structural similarity to dopamine, and, among indoles, N,N-dimethyltryptamine and bufotenin resemble serotonin (Figure 1). The hallucinogenic properties of these biogenic amine congeners are well documented for mescaline (Kapadia and Fayez, 1970) and for the indoles (Fujimori and Alpers, 1970).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alberici, M., Rodriquez de Lores Arnaiz, G., and De Robertis, E., 1965, Catechol-O-methyltransferase in nerve ending of rat brain, life Sci. 4: 1954

    Google Scholar 

  • Armstrong, M. D., McMillan, A., and Shaw, K. N. F., 1957, 3-methoxy-4-hydroxy-D-mandelic Acid, a urinary metabolite of norepinephrine, Biochim. Biophys. Acta 25: 422.

    Google Scholar 

  • Assicot, M., and Bohuon, C., 1971, Presence of two distinct catechol-O-methyltransferase activities in red blood cells, Biochimie 53: 871.

    Article  PubMed  CAS  Google Scholar 

  • Axelrod, J., 1957, O-Methylation of epinephrine and other catechols in vitro and in vivo, Science 126: 400.

    Article  PubMed  CAS  Google Scholar 

  • Axelrod, J., 1961, Enzymatic formation of psychotomimetic metabolites from normally occurring compounds, Science 134: 343.

    Article  PubMed  CAS  Google Scholar 

  • Axelrod, J., 1965, The formation and metabolism of physiologically active compounds by Nand O-methyltransferases, in: Transmethylation and Methionine Biosynthesis ( S. K. Shapiro, and F. Schlenk, eds.), p. 71, University of Chicago Press, Chicago.

    Google Scholar 

  • Axelrod, J., and Vesell, E. S., 1970, Heterogeneity of N- and O-methyltransferases, Mol. Pharmacol. 6: 78.

    CAS  Google Scholar 

  • Barbeau, A., Singh, P., and Joubert, M., 1966, Effect of 3,4-dimethoxyphenylethylamine injections on catecholamine metabolism in rats and monkeys, Life Sci. 5: 757.

    Article  PubMed  CAS  Google Scholar 

  • Benington, F., and Morin, R. D., 1968, Enzymatic 5-hydroxylation of 3-methoxytyramine Experientia 24:33.

    Google Scholar 

  • Bindler, E., Sanghvi, I., and Gershon, S., 1968, Pharmacological and behavioral characteristics of 3,4-dimethoxyphenylethylamine and its N-acetyl derivative, Arch. Intern. Pharmacodyn. 176:1.

    CAS  Google Scholar 

  • Blaschke, E., and Hertting, G., 1971, Enzymic methylation of L-ascorbic acid by catechol-Omethyltransferase, Biochem. Pharmacol. 20: 1363.

    Article  CAS  Google Scholar 

  • Bridger, W. H., and Mandel, I. J., 1967, The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response, Life Sci. 6: 775.

    Article  PubMed  CAS  Google Scholar 

  • Cantoni, G. L., 1952, The nature of the active methyl donor formed enzymatically from Lmethionine and adenosinetriphosphate, J. Am. Chem. Soc. 74: 2942

    Article  CAS  Google Scholar 

  • Charalampous, K. D., 1971, Comparison of metabolism of mescaline and 3,4dimethoxyphenylethylamine in humans, Behay. Neuropsychiat. 2: 26.

    CAS  Google Scholar 

  • Charalampous, K. D., and Tansey, L. W., 1967, Metabolic fate of 13-(3,4-dimethoxyphenyl)ethylamine in man, J. Pharmacol. Exptl. Therap. 155: 318.

    CAS  Google Scholar 

  • Chang, T., Okerholm, R. A., and Glazko, A. J., 1972, A 3-O-methylated catechol metabolite of diphenylhydantoin (dilantin) in rat urine, Res. Commun Chem. Path. Pharmacol. 4: 13.

    CAS  Google Scholar 

  • Cohn, C. K., Dunner, D. L., and Axelrod, J., 1970, Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder, Science 170: 1323.

    Article  PubMed  CAS  Google Scholar 

  • Creveling, C. R., Morris, N., Shimizu, H., Ong, H. H., and Daly, J. W., 1972, Catechol-Omethyltransferase IV. Factors affecting m-and pémethylation of substituted catechols, Mol. Pharmacol. 8: 398.

    PubMed  CAS  Google Scholar 

  • Daly, J. W., and Manian, A. A., 1969, The action of catechol-O-methyltransferase on 7,8dihydroxychlorpromazine-formation of 7-hydroxy-8-methoxychlorpromazine and 8hydroxy-7-methoxy chlorpromazine, Biochem. Pharmacol. 18: 1235.

    Article  PubMed  CAS  Google Scholar 

  • Daly, J., Axelrod, J., and Witkop, B., 1962, Methylation and demethylation in relation to the in vitro metabolism of mescaline, Ann. N.Y. Acad. Sci. 96: 37.

    Article  PubMed  CAS  Google Scholar 

  • Daly, J., Inscoe, J. K., and Axelrod, J., 1965, The formation of O-methylated catechols by microsomal hydroxylation of phenol and subsequent enzymatic catechol O-methylation. Substrate specificity, J. Med. Chem. 8: 153.

    Article  PubMed  CAS  Google Scholar 

  • Dear, E. M. A., and Malcolm, J. L., 1967, A study of the effect of 3,4dimethoxyphenylethylamine on cortical evoked potentials in the rat, Intern. J. Neuropharmacol. 6: 529.

    Article  CAS  Google Scholar 

  • Deguchi, T., and Barchas, J., 1971, Inhibition of transmethylations of biogenic amines by Sadenosylhomocysteine, J. Biol. Chem. 246: 3175.

    PubMed  CAS  Google Scholar 

  • Ernst, A. M., 1965, Relation between the structure of certain methoxyphenethylamine derivatives and the occurrence of a hypokinetic rigid syndrome, Psychopharmacologia 7: 383.

    Article  PubMed  CAS  Google Scholar 

  • Faurbye, A., 1968, The role of amines in the etiology of schizophrenia, Comprehensive Psy-chiat. 9:155.

    Article  CAS  Google Scholar 

  • Folkers, K., 1967, Research on coenzyme Q, in: Phenolic Compounds and Metabolic Regulation (B. J. Finkle, and V. C. Runeckles, eds.), p. 94, Appleton-Century-Crofts, New York.

    Google Scholar 

  • Frere, J. M., and Verly, W. G., 1971, Catechol-O-methyltransferase. The para-and meta-O-methylations of noradrenaline, Biochim. Biophys. Acta 235: 73.

    PubMed  CAS  Google Scholar 

  • Friedhoff, A. J., and Alpert, M., 1973, A dopaminergic-cholinergic mechanism in production of psychotic symptoms, Biol. Psychiat. 6: 165.

    PubMed  CAS  Google Scholar 

  • Friedhoff, A. J., and Hollister, L. E., 1966, Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans, Biochem. Pharmacol. 15: 269.

    Article  PubMed  CAS  Google Scholar 

  • Friedhoff, A. J., and Schweitzer, J. W., 1968, An effect of N-acetyl-dimethoxyphenethylamine, Diseases Nervous System 29: 455.

    Google Scholar 

  • Friedhoff, A. J., and Van Winkle, E., 1962, Isolation and characterization of a compound from the urine of schizophrenics, Nature 194: 897.

    Article  CAS  Google Scholar 

  • Friedhoff, A. J., and Van Winkle, E., 1963, Conversion of dopamine to 3,4-dimethoxyphenylacetic acid in schizophrenic patients, Nature 199: 1271.

    Article  PubMed  CAS  Google Scholar 

  • Friedhoff, A. J., and Van Winkle, E., 1964, Biological O-methylation and schizophrenia, Psychiat. Res. Rep. Am. Psychiat. Assoc. 19: 149.

    CAS  Google Scholar 

  • Friedhoff, A. J., Schweitzer, J. W., and Miller, J. C., (1972a). The enzymatic formation of 3,4di-O-methylated dopamine metabolites by mammalian tissues, Res. Commun Chem. Path. Pharmacol. 3: 293.

    CAS  Google Scholar 

  • Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972b, Biosynthesis of mescaline and Nacetylmescaline by mammalian liver, Nature 237: 454.

    Article  PubMed  CAS  Google Scholar 

  • Friedhoff, A. J., Schweitzer, J. W., Miller, J. C., and Van Winkle, E., 1972c, Guaiacol-Omethyltransferase: A mammalian enzyme capable of forming di-O-methylcatecholamine derivatives, Experientia 28: 517.

    Article  PubMed  CAS  Google Scholar 

  • Fujimori, M., and Alpers, H. S., 1970, Psychotomimetic compounds in man and animals, in: Biochemistry, Schizophrenias, and Affective Illnesses, ( H. E. Himwich, ed.), p. 361, Williams and Wilkins Co., Baltimore.

    Google Scholar 

  • Gustayson, K. H., Wetterberg, L., Backstrom, M., and Ross, S. B., 1973, Catechol-O-methyl-transferase activity in erythrocytes in Down’s syndrome, Clin. Genet. 4: 279.

    Article  Google Scholar 

  • Hartley, R., and Smith, J. A., 1973, Formation in vitro of N-acetyl-3,4-dimethoxyphenethylamine by pineal hydroxyindole-O-methyltransferase, Biochem. Pharmacol. 22: 2425.

    Article  PubMed  CAS  Google Scholar 

  • Hollister, L. E., and Friedhoff, A. J., 1966, Effects of 3,4-dimethoxyphenylethylamine in man, Nature 210: 1377.

    Article  PubMed  CAS  Google Scholar 

  • Kapadia, G. J., and Fayez, M. B. E., 1970, Peyote constituents: chemistry, biogenesis and biological effects, J. Pharm. Sci. 59: 1699.

    Article  PubMed  CAS  Google Scholar 

  • Levis, D. J., and Caldwell, D. F., 1971, The effects of a low dose of mescaline and 3,4dimethoxyphenylethylamine under two levels of adversive stimulation, Biol. Psychiat. 3: 251.

    PubMed  CAS  Google Scholar 

  • Mandell, A. J., and Morgan, M., 1970, Human brain enzyme makes indole hallucinogens, Proc. Am. Psycho!. Assoc. p. 228.

    Google Scholar 

  • Masri, M. S., Robbins, D. J., Emerson, O. H., and De Eds, F., 1964, Selective para-or metaO-methylation with catechol-O-methyltransferase from rat liver, Nature 202: 878.

    Article  PubMed  CAS  Google Scholar 

  • Matthysse, S., and Baldessarini, R. J., 1972, S-Adenosylmethionine and catechol-O-methyltransferase in schizophrenia, Am. J. Psychiat. 128: 1310.

    PubMed  CAS  Google Scholar 

  • McKenzie, G. M., and White, H. L., 1973, Evidence for the methylation of apomorphine by catechol-O-methyltransferase in vivo and in vitro, Biochem. Pharmacol. 22: 2329.

    CAS  Google Scholar 

  • Osmond, H., and Smythies, J., 1952, Schizophrenia: a new approach, J. Mental Sci. 98: 309.

    CAS  Google Scholar 

  • Pollin, W., Cardon, P. V., and Kety, S. S., 1961, Effects of amino acid feeding in schizophrenic patients treated with iproniazid, Science 133: 104.

    Article  PubMed  CAS  Google Scholar 

  • Price, J., 1969, The metabolites of isovanillic acid in man, with special reference to the formation of 3,4-dimethoxybenzoic acid, Clin. Chim. Acta 25: 31.

    Article  CAS  Google Scholar 

  • Schweitzer, J. W., and Friedhoff, A. J., 1966, The metabolism of a-C-3,4dimethoxyphenethylamine, Biochem. Pharmacol. 15: 2097.

    Article  PubMed  CAS  Google Scholar 

  • Schweitzer, J. W., Stone, E. A., and Friedhoff, A. J., 1973, Increased in vitro O-methylation in swim-stressed rats, Presented at the 4th meeting of the International Society for Neurochemistry, Tokyo.

    Google Scholar 

  • Shulgin, A. T., Sargent, T., and Naranjo, C., 1969, Structure-activity relationships of one-ring psychotomimetics, Nature 221: 537.

    Article  PubMed  CAS  Google Scholar 

  • Smythe, G. A., and Lazarus, L., 1973, Blockade of the dopamine-inhibitory control of prolactin secretion in rats by 3,4-dimethoxyphenylethylamine (3,4-di-O-methyldopamine), Endocrinology 93: 147.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, S. H., and Merril, C. R., 1965, A relationship between the hallucinogenic activity of drugs and their electronic configuration, Proc. Natl. Acad. Sci. (U.S.) 54: 258.

    Article  CAS  Google Scholar 

  • Takeo, Y., and Himwich, H. E., 1965, Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal, Science 150: 1309.

    Article  PubMed  CAS  Google Scholar 

  • Vacca, L., Fujimori, M., Davis, S. H., and Marrazzi, A. S., 1968, Cerebral synaptic transmission and behavioral effects of dimethoxyphenylethylamine: a potential psychotogen, Science 160: 95.

    Article  PubMed  CAS  Google Scholar 

  • Van Praag, H. M., 1967, The possible significance of cerebral dopamine for neurology and psychiatry, Psychiat. Neurol. Neurochir. 70: 361.

    PubMed  Google Scholar 

  • Weil-Malherbe, H., and Szara, S. I., 1971, The Biochemistry of Functional and Experimental Psychoses, Charles C. Thomas, Springfield.

    Google Scholar 

  • Wyatt, R. J., Termini, B. A., and Davis, J., 1971, Biochemical and sleep studies of schizophrenia: a reveiw of the literature-1960–1970. Part I. Biochemical studies, Schizophrenia Bull. 4: 10.

    Google Scholar 

  • Youdim, M. B. H., Collins, C. G. S., and Sandler, M., 1969, Multiple forms of rat brain monoamine oxidase, Nature 223: 626.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Friedhoff, A.J., Schweitzer, J.W. (1975). Mammalian Biosynthesis of Potential Psychotogens Derived from Dopamine. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3135-3_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3137-7

  • Online ISBN: 978-1-4684-3135-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics